1. Home
  2. LEXX vs HYFM Comparison

LEXX vs HYFM Comparison

Compare LEXX & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • HYFM
  • Stock Information
  • Founded
  • LEXX 2004
  • HYFM 1977
  • Country
  • LEXX Canada
  • HYFM United States
  • Employees
  • LEXX N/A
  • HYFM N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • HYFM Industrial Machinery/Components
  • Sector
  • LEXX Health Care
  • HYFM Industrials
  • Exchange
  • LEXX Nasdaq
  • HYFM Nasdaq
  • Market Cap
  • LEXX 19.6M
  • HYFM 17.1M
  • IPO Year
  • LEXX N/A
  • HYFM 2020
  • Fundamental
  • Price
  • LEXX $0.89
  • HYFM $3.64
  • Analyst Decision
  • LEXX Strong Buy
  • HYFM Hold
  • Analyst Count
  • LEXX 1
  • HYFM 2
  • Target Price
  • LEXX $5.00
  • HYFM $7.00
  • AVG Volume (30 Days)
  • LEXX 146.9K
  • HYFM 8.4K
  • Earning Date
  • LEXX 07-22-2025
  • HYFM 08-07-2025
  • Dividend Yield
  • LEXX N/A
  • HYFM N/A
  • EPS Growth
  • LEXX N/A
  • HYFM N/A
  • EPS
  • LEXX N/A
  • HYFM N/A
  • Revenue
  • LEXX $525,923.00
  • HYFM $176,650,000.00
  • Revenue This Year
  • LEXX $0.62
  • HYFM $5.45
  • Revenue Next Year
  • LEXX $14.19
  • HYFM $5.33
  • P/E Ratio
  • LEXX N/A
  • HYFM N/A
  • Revenue Growth
  • LEXX 29.95
  • HYFM N/A
  • 52 Week Low
  • LEXX $0.82
  • HYFM $1.50
  • 52 Week High
  • LEXX $4.38
  • HYFM $8.55
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 41.23
  • HYFM 50.82
  • Support Level
  • LEXX $0.86
  • HYFM $3.51
  • Resistance Level
  • LEXX $1.05
  • HYFM $3.94
  • Average True Range (ATR)
  • LEXX 0.06
  • HYFM 0.28
  • MACD
  • LEXX 0.00
  • HYFM -0.02
  • Stochastic Oscillator
  • LEXX 30.70
  • HYFM 48.39

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.

Share on Social Networks: